Plexāā invited to Showcase BLOOM⁴³ at Launch of National Women's Health Strategy
[Royal College of Obstetricians and Gynaecologists, London, March 2024] – Plexāā is excited to announce that they are invited to showcase their innovative device, BLOOM⁴³, at the launch of the Women’s Health Strategy at the Royal College of Obstetricians and Gynaecologists (RCOG). This significant event highlighted the commitment to advancing women’s health in the UK and featured presentations by distinguished leaders, including Dame Lesley Regan, Women's Health Ambassador for the UK government, Maria Caulfield, Former Minister of State for Health of the United Kingdom, and Health Secretary Victoria Atkins.
Accompanied by Plexāā’s Patient Champion, Carly Moosah, Plexāā showcased their first innovation, BLOOM4³, a device designed to improve surgical outcomes for women undergoing breast surgery. The launch provided a vital platform to engage with healthcare professionals and stakeholders focused on enhancing women’s health services.
“We are honoured to be part of this important initiative,” said Dr Saahil Mehta, Founder of Plexāā. “Our mission aligns perfectly with the goals of the Women’s Health Strategy, and we are committed to making a positive impact on the lives of women through our innovative technology with a vision to develop products in the obstetrics space and become standard of care for preparing for surgery.”
The Women’s Health Strategy aims to address the unique healthcare needs of women, and Plexāā is proud to contribute to this vision with our cutting-edge solutions.
For more information about Plexāā and BLOOM⁴³, please visit www.bloom43.com and sign up to our newsletter to keep in touch
About Plexāā
Plexāā is a pioneering UK MedTech company focused on improving surgical outcomes through innovative solutions. Their flagship device, BLOOM⁴³ enables patients to supraphysiologically precondition their skin, potentially reducing the risk of wound healing complications such as infection and skin necrosis, which affect 1 in 3 women undergoing breast surgery.
BLOOM⁴³ is the world’s first fully wearable device worn next to the skin before breast surgery. By gently warming the area to stimulate the release of Heat Shock Proteins (HSPs). These naturally occurring proteins cause the release of carbon monoxide into the tissue which vasodilates the blood vessels and improves the blood flow to the skin. This improved blood flow primes the skin to heal and has been shown to prevent wound healing complications in proof-of-concept clinical trials.
Plexāā is also exploring the application of this technology in other surgical fields, including obstetrics for C-sections, orthopedics for joint operations, and general and vascular surgery, with a commitment to improving pre-operative preparation for surgery and patient outcomes.
Media Contact: